Medivir AB (publ)

kr 1.20As of Sun 8 Nov 2026, 12:00 UTC
STO:MVIRHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (30.28%)
Div yield —
ROE (49.97%)
Biotechnology
Beta (5Y) 0.18
PE TTM —
TSR TTM 122.22%
Mkt cap kr 748.8M
ROIC (194.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.43
18.77%
(88.29%)
Hold 1|7|7|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.02
0.02
0.02
0.02
12.02%
6.14%
2.07%
3.52%
Revenuekr M
33.81
33.57
34.74
36.78
(1.69%)
(2.71%)
2.65%
8.47%
Peers (US$75.71M)
Cap (US$)
PE
86.51M
—
85.32M
22.67x
Capital
TTM
5Y
10Y
Leveragex
2.026
1.078
0.578
EBIT/Intx
0.930
0.157
0.161
Own earn%
118.09
0.61
0.69
Sh yield%
25.75
25.49
27.29
Owners
Insiders/Inst%
9.59
20.12
Short interest%
3.13
SBC / revenue%
4.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
6–14
$1 testx
—
Incr. ROIC%
0